Release Date: 04/03/16 19:46 Summary: Noteholder Notice of Meeting Price Sensitive: No Download Document 568.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%